Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01691105 · ClinicalTrials.gov registry record · NA

Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
1,044
Enrollment target

NCT01691105 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,044 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01691105, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
1,044 participants
Enrollment target

Study Summary

This study will implement and test the effectiveness and cost-effectiveness of a tobacco cessation intervention (Academic Detailing + Integrated Tobacco Order Set - AD + ITOS) for adults admitted to the hospital. The intervention will begin during the hospital stay and continue after discharge. The intervention will use resources easily available to most acute care hospitals: computerized physician order entry, physician and nurse education, staff meetings for physicians, nurses and allied health professionals, online learning capabilities, faxing to primary care providers (PCPs), and the telephone counseling and support available from a state smokers' quitline (QL). The investigators hypothesize that the subjects in the intervention arm (AD + ITOS) will be more likely to achieve tobacco abstinence at 12 months post hospital stay than subjects in the control arm (Academic Detailing - AD). Tobacco abstinence will be assessed by self report and biochemical verification (exhaled carbon monoxide reading).

Interventions

  • OTHER AD + Integrated Tobacco Order Set

Trial Details

FieldValue
Enrollment Target 1,044 participants
Start Date 2013-08
Est. Completion 2016-09
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT01691105

The ClinicalTrials.gov registry entry for NCT01691105 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,044 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which AD + Integrated Tobacco Order Set is the first listed.

NCT01691105 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01691105 about?

NCT01691105 is a clinical study titled "Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers". This study will implement and test the effectiveness and cost-effectiveness of a tobacco cessation intervention (Academic Detailing + Integrated Tobacco Order Set - AD + ITOS) for adults admitted to the hospital. The intervention will begin during the hospital stay and continue after discharge. The ...

What is the current status of trial NCT01691105?

This trial is currently completed. It is a NA study. The enrollment target is 1,044 participants. The study started on 2013-08. Estimated completion is 2016-09.

What interventions are being tested in trial NCT01691105?

The interventions under investigation include: AD + Integrated Tobacco Order Set (OTHER).

Who is sponsoring clinical trial NCT01691105?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.